Literature DB >> 26648499

New insights on diabetes and bone metabolism.

Carolina A Moreira1, Fellype C Barreto2, David W Dempster3.   

Abstract

Diabetes mellitus is a common chronic metabolic disease worldwide whose prevalence has increased during the last decades. Besides its more commonly recognized complications, such as macrovascular disease, retinopathy, nephropathy and neuropathy, diabetes related bone disease has gained growing attention. Diabetic patients are more prone to fracture than the general population as well as to low turnover bone disease in the chronic kidney disease setting. In this review, we discuss the relationship between diabetes and bone as well as the pathogenesis of bone fragility in T2D.

Entities:  

Mesh:

Year:  2015        PMID: 26648499     DOI: 10.5935/0101-2800.20150077

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  5 in total

Review 1.  Diabetes Mellitus and Dental Implants: A Systematic Review and Meta-Analysis.

Authors:  Yasmin Al Ansari; Halime Shahwan; Bruno Ramos Chrcanovic
Journal:  Materials (Basel)       Date:  2022-04-29       Impact factor: 3.748

2.  Association of plasma neutrophil gelatinase-associated lipocalin and thoracic aorta calcification in maintenance hemodialysis patients with and without diabetes.

Authors:  Kai Wei; Gesheng Song; Linhe Xi; Juan Chen; Chuancai Sun; Ping Chen; Yong Wei; Li Wang; Xianglei Kong; Yang Li; Dongmei Xu; Xiaoyan Jia
Journal:  BMC Nephrol       Date:  2022-04-22       Impact factor: 2.585

3.  Osteoporotic hip fracture-Comorbidities and factors associated with in-hospital mortality in the elderly: A nine-year cohort study in Brazil.

Authors:  Viviane Cristina Uliana Peterle; Maria Rita Carvalho Garbi Novaes; Paulo Emiliano Bezerra Junior; João Carlos Geber Júnior; Rodrigo Tinôco Magalhães Cavalcante; Jurandi Barrozo da Silva Junior; Ray Costa Portela; Ana Patricia de Paula
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

4.  Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.

Authors:  Andre Gustavo Daher Vianna; Claudio Silva de Lacerda; Luciana Muniz Pechmann; Michelle Garcia Polesel; Emerson Cestari Marino; Victoria Zeghbi Cochenski Borba; Fellype de Carvalho Barreto
Journal:  Diabetol Metab Syndr       Date:  2017-05-15       Impact factor: 3.320

Review 5.  The impact of type 2 diabetes on bone metabolism.

Authors:  Claudia Pinheiro Sanches; Andre Gustavo Daher Vianna; Fellype de Carvalho Barreto
Journal:  Diabetol Metab Syndr       Date:  2017-10-19       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.